Description
NimorazoleisahypoxicmodifierandrADIosensitizerthatexhibitsanticancerandanti-parasiticactivities.Nimorazoleisclinicallyusedtotreattrichomoniasis.Nimorazolefeaturesastructuresimilartothatofothernitroimidazoleantimicrobialcompounds.
NimorazoleisahypoxicmodifierandrADIosensitizerthatexhibitsanticancerandanti-parasiticactivities.Nimorazoleisclinicallyusedtotreattrichomoniasis.Nimorazolefeaturesastructuresimilartothatofothernitroimidazoleantimicrobialcompounds.
CasNo. | 6506-37-2 |
---|---|
Purity | ≥98% |
Formula | C9H14N4O3 |
FormulaWt. | 226.24 |
IUPACName | 4-[2-(5-Nitro-1H-imidazol-1-yl)ethyl]morpholine |
StoreTemp | -20°C |
---|---|
ShipTemp | Ambient |
InfoSheet | N3350InfoSheetPDF |
---|
MetwallyMA,FrederiksenKD,OvergaardJ.Complianceandtoxicityofthehypoxicradiosensitizernimorazoleinthetreatmentofpatientswithheadandnecksquamouscellcarcinoma(HNSCC).ActaOncol.2014May;53(5):654-61.PMID:24328536.
OvergaardJ.Clinicalevaluationofnitroimidazolesasmodifiersofhypoxiainsolidtumors.OncolRes.1994;6(10-11):509-18.PMID:7620219.
OvergaardJ,OvergaardM,NielsenOS,etal.AcomparativeinvestigationofnimorazoleandmisonidazoleashypoxicradiosensitizersinaC3Hmammarycarcinomainvivo.BrJCancer.1982Dec;46(6):904-11.PMID:7150484.
WigfieldAS.Trichomonalvaginitis.A24-hrregimenofnimorazolecomparedwitha7-dayregimenofmetronidazole.BrJVenerDis.1975Feb;51(1):54-6.PMID:1092425.